Oct 19, 2016, 03.42 PM | Source: Moneycontrol.com
Net Sales are expected to increase by 12.4 percent Q-o-Q (down 17.8 percent Y-o-Y) to Rs 210 crore, according to Centrum.
Centrum Broking (more)
, Centrum Broking |
To read the full report click here
Centrum recommended hold rating on Marksans Pharma
"USFDA (US Food & Drug Administration) has granted
Marksans Pharma announced that USFDA has granted a